Cardiothyreosis clinical data | All patients (n = 150) | Cardiothyreosis inaugural (n = 70) | Age > 50 years (n = 49) |
Palpitation | 97.3% | 98% | 100% |
Tachycardia | 64.6% | 64.7% | 52% |
Heart dyspnea stages I and II | 21.3% | 24.2% | 22.4% |
Heart dyspnea stage III | 64.6% | 58.5% | 63.2% |
Heart dyspnea stage IV | 14% | 17.1% | 12.2% |
Cardiovascular excitability | 24% | 22.8% | 20.4% |
Orthopnea | 13.3% | 17.1% | 12.2% |
Acute pulmonary edema | 3.3% | 4.2% | 4% |
Edema of lower limbs | 66% | 61.4% | 63.2% |
jugular vein high pressure | 70.6% | 69% | 73.4% |
Hepatomegaly | 11.3% | 11.4% | 12.2% |
Ascites | 2.6% | 4.2% | 0% |
Pleural effusion | 0.6% | 0% | 2% |
Cardiac rhythm disorders | 42.6% | 41.4% | 38.7% |
Gallop | 8% | 7.1% | 4% |
Heart Murmur | 22% | 24.2% | 12.2% |